BBR Kroon

818 total citations
13 papers, 162 citations indexed

About

BBR Kroon is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, BBR Kroon has authored 13 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 3 papers in Surgery. Recurrent topics in BBR Kroon's work include Cutaneous Melanoma Detection and Management (6 papers), Breast Lesions and Carcinomas (3 papers) and Virus-based gene therapy research (3 papers). BBR Kroon is often cited by papers focused on Cutaneous Melanoma Detection and Management (6 papers), Breast Lesions and Carcinomas (3 papers) and Virus-based gene therapy research (3 papers). BBR Kroon collaborates with scholars based in Netherlands and Switzerland. BBR Kroon's co-authors include Omgo E. Nieweg, Emiel J. Rutgers, Simon Horenblas, Pieter J. Tanis, R.A. Valdés Olmos, Renato A. Valdés Olmos, Anne P. Lont, Hs Koops, J. Gérain and D Liénard and has published in prestigious journals such as The Journal of Urology, European Journal of Nuclear Medicine and Molecular Imaging and Melanoma Research.

In The Last Decade

BBR Kroon

13 papers receiving 159 citations

Peers

Countries citing papers authored by BBR Kroon

Since Specialization

Citations

This map shows the geographic impact of BBR Kroon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by BBR Kroon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BBR Kroon more than expected).

Fields of papers citing papers by BBR Kroon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by BBR Kroon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by BBR Kroon. The network helps show where BBR Kroon may publish in the future.

Co-authorship network of co-authors of BBR Kroon

This figure shows the co-authorship network connecting the top 25 collaborators of BBR Kroon. A scholar is included among the top collaborators of BBR Kroon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with BBR Kroon. BBR Kroon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	MORBIDITY OF DYNAMIC SENTINEL NODE BIOPSY IN PENILE CARCINOMA 2005 ·The Journal of Urology ·BBR Kroon, Anne P. Lont, Renato A. Valdés Olmos, Omgo E. Nieweg, Simon Horenblas	46
2	Reproducibility study of lymphoscintigraphy: excisional biopsy of breast lesions changes drainage patterns 2004 ·European Journal of Cancer Supplements ·Susanne H. Estourgie, (unknown), Omgo E. Nieweg, (unknown), Emiel J. Rutgers, BBR Kroon	1
3	Isolated limb perfusion for melanoma: technical aspects 2003 ·Heimen Schraffordt Koops, (unknown), BBR Kroon, (unknown), HJ Hoekstra	6
4	The hidden sentinel node in breast cancer 2002 ·European Journal of Nuclear Medicine and Molecular Imaging ·Pieter J. Tanis, (unknown), Omgo E. Nieweg, R.A. Valdés Olmos, Emiel J. Rutgers, (unknown), BBR Kroon	60
5	Lymphoscintigraphy to identify unusual locations of sentinel lymph nodes in patients with breast cancer 1999 ·Data Archiving and Networked Services (DANS) ·Liesbeth Jansen, OE Nieweg, (unknown), (unknown), PL Jager, (unknown), DA Piers, Emiel J. Rutgers, (unknown), BBR Kroon	1
6	Sentinel node biopsy in head/neck melanoma 1997 ·Melanoma Research ·B.A.E. Kapteijn, (unknown), Omgo E. Nieweg, A. J. M. Balm, (unknown), (unknown), Cornelis A. Hoefnagel, D.A. Piers, BBR Kroon	1
7	Long-term functional morbidity after mild hyperthermic isolated limb perfusion (ILP) with melphalan 1997 ·Melanoma Research ·B. C. Vrouenraets, (unknown), Omgo E. Nieweg, Gooike W. van Slooten, J.A. van Dongen, BBR Kroon	1
8	Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma 1997 ·Melanoma Research ·(unknown), (unknown), (unknown), Omgo E. Nieweg, BBR Kroon	1
9	Is intra-operative evaluation of frozen sections a reliable method for sentinel modes in malignant melanoma? 1997 ·Melanoma Research ·(unknown), Omgo E. Nieweg, (unknown), D.A. Piers, Harald J. Hoekstra, B.A.E. Kapteijn, J.L. Peterse, BBR Kroon	1
10	Accuracy of lymphoscintigraphy in indicating the number of sentinel lymph nodes 1997 ·Melanoma Research ·Omgo E. Nieweg, B.A.E. Kapteijn, R.A. Valdés Olmos, Cornelis A. Hoefnagel, BBR Kroon	2
11	Treatment of in-transit melanoma metastases with tumour necrosis factor (TNF-??) and chemotherapy administered in isolated limb perfusion (ILP) 1997 ·Melanoma Research ·Ferdy J. Lejeune, D Liénard, (unknown), BBR Kroon, A Eggermont	2
12	[Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience]. 1995 ·PubMed ·F. Lejeune, D. Liénard, A Eggermont, H. Schraffordt Koops, F. Rosenkaimer, J. Gérain, Joost M. Klaase, BBR Kroon, P.I.M. Schmitz	3
13	Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma. 1994 ·PubMed ·F. Lejeune, D Liénard, A Eggermont, Hs Koops, BBR Kroon, J. Gérain, F. Rosenkaimer, P.I.M. Schmitz	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact